Texas Yale Capital Corp’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$599K Hold
7,225
0.02% 317
2025
Q1
$586K Hold
7,225
0.02% 315
2024
Q4
$651K Sell
7,225
-15
-0.2% -$1.35K 0.03% 297
2024
Q3
$715K Hold
7,240
0.03% 299
2024
Q2
$671K Sell
7,240
-3,889
-35% -$361K 0.03% 294
2024
Q1
$1.06M Hold
11,129
0.05% 248
2023
Q4
$994K Hold
11,129
0.05% 248
2023
Q3
$813K Buy
11,129
+1,224
+12% +$89.4K 0.04% 255
2023
Q2
$824K Hold
9,905
0.04% 265
2023
Q1
$755K Hold
9,905
0.04% 275
2022
Q4
$822K Hold
9,905
0.05% 266
2022
Q3
$786K Hold
9,905
0.05% 260
2022
Q2
$736K Sell
9,905
-9,795
-50% -$728K 0.05% 269
2022
Q1
$1.77M Hold
19,700
0.1% 183
2021
Q4
$2.21M Hold
19,700
0.11% 163
2021
Q3
$2.48M Buy
19,700
+615
+3% +$77.3K 0.14% 139
2021
Q2
$2.58M Sell
19,085
-320
-2% -$43.3K 0.15% 134
2021
Q1
$2.63M Buy
19,405
+320
+2% +$43.4K 0.17% 120
2020
Q4
$2.69M Hold
19,085
0.18% 110
2020
Q3
$2.13M Hold
19,085
0.16% 126
2020
Q2
$2.14M Buy
19,085
+2,050
+12% +$230K 0.17% 121
2020
Q1
$1.32M Hold
17,035
0.13% 156
2019
Q4
$1.62M Hold
17,035
0.11% 174
2019
Q3
$1.3M Hold
17,035
0.09% 200
2019
Q2
$1.49M Sell
17,035
-17,035
-50% -$1.49M 0.11% 180
2019
Q1
$3.08M Buy
34,070
+17,035
+100% +$1.54M 0.12% 168
2018
Q4
$1.22M Sell
17,035
-900
-5% -$64.6K 0.11% 179
2018
Q3
$1.72M Hold
17,935
0.14% 145
2018
Q2
$1.71M Hold
17,935
0.15% 132
2018
Q1
$1.57M Sell
17,935
-1,440
-7% -$126K 0.14% 147
2017
Q4
$1.64M Buy
19,375
+900
+5% +$76.4K 0.14% 144
2017
Q3
$1.6M Sell
18,475
-75
-0.4% -$6.49K 0.14% 141
2017
Q2
$1.43M Buy
+18,550
New +$1.43M 0.13% 152
2015
Q3
Sell
-2,670
Closed -$224K 490
2015
Q2
$224K Hold
2,670
0.02% 445
2015
Q1
$201K Buy
+2,670
New +$201K 0.02% 459
2013
Q4
Sell
-4,965
Closed -$214K 316
2013
Q3
$214K Buy
+4,965
New +$214K 0.04% 277